I think the expectation of 2200 crores odd sales in q2 from torrent was a bit too much. Esp in view of increased competition and price erosion in abilify.
Domestic growth was lackslutre but it was a deliberate strategy by the management as oulined in concall post q2 results.
On positive side there are two news
First is that Dahej facility has started production in line with expectation and
Elimination (albeit for a short period) of DRL and Hetero from nexium opportunity.
Negative is that market itself is weak and pharma sector is hurt sentimentally by problems faced by DRL and Sun.
| Subscribe To Our Free Newsletter |
